相关实验视频

Updated: May 13, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

BIRC2阻断促进了肝细胞癌的免疫治疗

Lingyi Fu^1,2, Shuo Li^1,2, Jie Mei^1,3

¹State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Molecular cancer

|April 13, 2025

概括

细菌病毒IAP重复含有蛋白2 (BIRC2) 通过抑制T细胞反应驱动肝细胞癌 (HCC) 免疫逃避. 阻止BIRC2使HCC瘤对免疫攻击敏感,并提高免疫疗法的疗效.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

肝细胞癌 (HCC) 免疫疗法在肝细胞癌 (HCC) 中的有效性是有限的,因为免疫逃避的分子机制尚不清楚.
细菌病毒IAP重复含有蛋白2 (BIRC2) 被确定为HCC免疫逃避中的关键调节者.

研究的目的:

为了研究BIRC2在HCC免疫逃逸中的作用.
探索针对BIRC2在HCC中的治疗潜力.

主要方法:

全基因组的CRISPR/Cas9查以确定瘤内在基因.
在体外和体外的HCC模型来评估BIRC2功能.
探索BIRC2信号通路和BIRC2抑制剂的治疗疗效.

主要成果:

提高BIRC2表达与HCC患者的不良预后和免疫疗法耐药性相关.
BIRC2通过降解NIK,禁用非正规NFκB信号,并减少MHC-I表达来促进HCC免疫逃避.
抑制BIRC2增加了HCC细胞对免疫杀伤的敏感性,并增强了T细胞功能,导致显著的瘤生长抑制和改善了抗PD-1疗法的疗效.

结论:

BIRC2阻塞使HCC细胞对免疫攻击敏感,并增强T细胞抗瘤反应.
准BIRC2代表了一种有希望的策略,以克服HC的免疫疗法耐药性.

关键词:

在BIRC2中,有两种情况.肝细胞癌是肝细胞癌.免疫治疗是一种免疫疗法.在MHC-I中,MHC-I是最重要的.尼克尼克尼克是什么意思

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...